From May 31, 2023 to February 26, 2024, the company has repurchased 56,975,656 shares, representing 4.37% for $53.34 million. With this, the company has completed the repurchase of 56,975,656 shares, representing 4.37% for $53.34 million under the buyback announced on May 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.878 USD | -0.23% | 0.00% | +4.52% |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
05-02 | BioPharma Credit agrees USD400 million loan for oncology firm Novacure | AN |
1st Jan change | Capi. | |
---|---|---|
+4.52% | 1.07B | |
+5.34% | 12.82B | |
+12.72% | 9.62B | |
+9.66% | 5.64B | |
-0.50% | 5.56B | |
+6.41% | 5.23B | |
+17.95% | 4.63B | |
+18.80% | 4.53B | |
+2.81% | 4.07B | |
+6.22% | 3.94B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.